Cancer Proteomics Service
Cancer proteomics is the comprehensive study of proteins expressed in cancer cells and tissues, focusing on their expression levels, structures, functions, modifications, and interactions. By analyzing the complete proteome of cancer cells, researchers gain profound insights into the molecular mechanisms driving tumor development, progression, and metastasis. Cancer proteomics bridges the gap between genomics and functional biology, as proteins are the primary effectors of cellular functions influenced by genetic alterations. Applications of cancer proteomics are vast, including the discovery of novel biomarkers for early detection and diagnosis, identification of new therapeutic targets, elucidation of drug resistance mechanisms, and the advancement of personalized medicine approaches to tailor treatments based on an individual’s proteomic profile.
Figure 1. Proteomics Empowering Precision Oncology
Service at MtoZ Biolabs
MtoZ Biolabs offers a comprehensive Cancer Proteomics Service designed to accelerate your oncology research. Leveraging our extensive expertise and state-of-the-art mass spectrometry platforms, we provide in-depth proteomic analyses tailored to your specific needs. Our services encompass everything from global protein expression profiling to targeted analysis of post-translational modifications.
Figure 1. Workflow of Cancer Proteomics Service
Service Advantages
1. Advanced Analysis Platform: MtoZ Biolabs established an advanced Cancer Proteomics Service platform, guaranteeing reliable, fast, and highly accurate analysis service.
2. One-Time-Charge: Our pricing is transparent, no hidden fees or additional costs.
3. High-Data-Quality: Deep data coverage with strict data quality control. AI-powered bioinformatics platform integrates all cancer proteomics data, providing clients with a comprehensive data report.
4. Customizable Service: Personalized service to meet various research needs.
5. Fast Turnaround: The process from sample handling to report generation is efficient, shortening the analysis cycle.
Applications
1. Cancer Proteomics in Biomarker Development
Cancer Proteomics Service is a cornerstone for identifying reliable biomarkers in cancer diagnosis, prognosis, and treatment monitoring. By profiling the proteome of cancer tissues, blood, or other biological fluids, Cancer Proteomics Service uncovers proteins with altered expression or post-translational modifications that are unique to specific cancer types or stages. These biomarkers are critical for non-invasive diagnostic assays, enabling early detection and differentiation of tumor subtypes. Furthermore, Cancer Proteomics Service supports the validation of these biomarkers through large-scale studies, ensuring their clinical utility in patient stratification and therapeutic decision-making.
Tonry, C. L. et al. Diagnostics (Basel). 2016.
Figure 3. Proteomic Technology for Discovery and Evaluation of Protein Biomarkers
2. Cancer Proteomics in Cancer Mechanism Research
Understanding the molecular mechanisms underlying cancer progression is crucial for developing innovative treatments. Cancer Proteomics Service can profile the dynamic changes in the proteome during tumor initiation, metastasis, and therapy resistance, revealing key pathways and regulatory networks involved in cancer biology. This empowers researchers to unravel the intricate mechanisms of cancer, paving the way for novel therapeutic strategies.
Su, M. et al. Cancers (Basel). 2021.
Figure 4. Cancer Proteomics Helps Reveal the Mechanisms of Cancer Development
Deliverables
1. Comprehensive Experimental Details
2. Materials, Instruments, and Methods
3. Total Ion Chromatogram & Quality Control Assessment (project-dependent)
4. Data Analysis, Preprocessing, and Estimation (project-dependent)
5. Bioinformatics Analysis
6. Raw Data Files
How to order?
